dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 20, 2026

Meta Platforms: From Heavy AI CapEx to 2026 ROI?

View original at finance.yahoo.com
“Reality Labs (home to Meta's VR devices and metaverse projects) generated just over $2.1 billion in revenue but more than $17.7 billion in operating losses”
Verbatim excerpt from the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2025 capital expenditures will exceed $70 billion, approximately 70% higher than in 2024

    80% confidence

  • Time spent on Facebook rose 5% in Q3 2025

    80% confidence

  • Reels is running at a roughly $50 billion annualized revenue rate

    80% confidence

  • Threads usage jumped 10% in Q3 2025

    80% confidence

  • Instagram video consumption is up more than 30% year-over-year

    80% confidence

  • Meta has spent over $40 billion on R&D to date, with a significant portion allocated to AI/ML

    80% confidence

  • 2026 expenses will likely grow at a significantly faster rate than in 2025, largely due to infrastructure and personnel costs as new data center capacity comes online

    80% confidence

  • Lead-gen campaigns using Advantage+ show a 14% lower cost per lead than traditional campaigns

    80% confidence

  • Advantage+ is handling over $60 billion in annual ad spend

    80% confidence

  • Average price per ad rose 10% year-over-year in Q3 2025, credited to AI

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Meta Platforms: From Heavy AI CapEx to 2026 ROI?: Source | Via News | fr.via.news